Cargando…
Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines?
BACKGROUND: Guidelines are published by international gastroenterology societies regarding the management of ulcerative colitis (UC) and Crohn’s disease (CD) to help clinicians to provide high-quality patient care. We examined the guidelines for the quality and strength of evidence used to develop t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560035/ https://www.ncbi.nlm.nih.gov/pubmed/34733526 http://dx.doi.org/10.1093/gastro/goab009 |
_version_ | 1784592864514146304 |
---|---|
author | Goldowsky, Alexander Sen, Rohan Hoffman, Gila Feuerstein, Joseph D |
author_facet | Goldowsky, Alexander Sen, Rohan Hoffman, Gila Feuerstein, Joseph D |
author_sort | Goldowsky, Alexander |
collection | PubMed |
description | BACKGROUND: Guidelines are published by international gastroenterology societies regarding the management of ulcerative colitis (UC) and Crohn’s disease (CD) to help clinicians to provide high-quality patient care. We examined the guidelines for the quality and strength of evidence used to develop the recommendations, methods for grading evidence, differences in disease-specific recommendations, conflicts of interest, and plans for guideline updates. METHODS: A systematic search was performed on PubMed using “ulcerative colitis,” “Crohn’s disease,” and “guidelines” in April 2019. International gastroenterology society websites were searched for UC- and CD-specific guidelines. Guidelines from 12 societies were examined by two authors. Chi-squared tests were used for comparing evidence-level grades, strength of recommendations, and reported conflicts of interest. Linear-regression modeling was used to evaluate the relationship between the number of authors and the number of recommendations in a given guideline. RESULTS: Of 28 guidelines reviewed, 25 (89%) used a total of three different systems to grade the level of evidence and 2 (7%) used an unknown system. Three (11%) reviewed guidelines did not provide a conflict-of-interest statement, while three (11%) provided a timeline for guideline updates. Of 1,265 total statements examined, 246 (19%) reported no grade of evidence quality or explicitly stated that the recommendation was based on “expert opinion.” One hundred and thirty-five (22%) UC recommendations were noted to be “weak/conditional” and 95 (16%) did not have a recommendation strength. Two hundred and forty-two (37%) CD recommendations were noted to be “weak/conditional” and 151 (23%) did not have a recommendation strength. CONCLUSION: The majority of UC and CD guidelines are based on a low/very low quality of evidence and are further weakened due to the lack of homogeneity in specific aspects of management recommendations as well as conflicts of interest. |
format | Online Article Text |
id | pubmed-8560035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-85600352021-11-02 Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? Goldowsky, Alexander Sen, Rohan Hoffman, Gila Feuerstein, Joseph D Gastroenterol Rep (Oxf) Original Articles BACKGROUND: Guidelines are published by international gastroenterology societies regarding the management of ulcerative colitis (UC) and Crohn’s disease (CD) to help clinicians to provide high-quality patient care. We examined the guidelines for the quality and strength of evidence used to develop the recommendations, methods for grading evidence, differences in disease-specific recommendations, conflicts of interest, and plans for guideline updates. METHODS: A systematic search was performed on PubMed using “ulcerative colitis,” “Crohn’s disease,” and “guidelines” in April 2019. International gastroenterology society websites were searched for UC- and CD-specific guidelines. Guidelines from 12 societies were examined by two authors. Chi-squared tests were used for comparing evidence-level grades, strength of recommendations, and reported conflicts of interest. Linear-regression modeling was used to evaluate the relationship between the number of authors and the number of recommendations in a given guideline. RESULTS: Of 28 guidelines reviewed, 25 (89%) used a total of three different systems to grade the level of evidence and 2 (7%) used an unknown system. Three (11%) reviewed guidelines did not provide a conflict-of-interest statement, while three (11%) provided a timeline for guideline updates. Of 1,265 total statements examined, 246 (19%) reported no grade of evidence quality or explicitly stated that the recommendation was based on “expert opinion.” One hundred and thirty-five (22%) UC recommendations were noted to be “weak/conditional” and 95 (16%) did not have a recommendation strength. Two hundred and forty-two (37%) CD recommendations were noted to be “weak/conditional” and 151 (23%) did not have a recommendation strength. CONCLUSION: The majority of UC and CD guidelines are based on a low/very low quality of evidence and are further weakened due to the lack of homogeneity in specific aspects of management recommendations as well as conflicts of interest. Oxford University Press 2021-03-29 /pmc/articles/PMC8560035/ /pubmed/34733526 http://dx.doi.org/10.1093/gastro/goab009 Text en © The Author(s) 2021. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Goldowsky, Alexander Sen, Rohan Hoffman, Gila Feuerstein, Joseph D Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title | Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title_full | Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title_fullStr | Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title_full_unstemmed | Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title_short | Is there a standardized practice for the development of international ulcerative colitis and Crohn’s disease treatment guidelines? |
title_sort | is there a standardized practice for the development of international ulcerative colitis and crohn’s disease treatment guidelines? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560035/ https://www.ncbi.nlm.nih.gov/pubmed/34733526 http://dx.doi.org/10.1093/gastro/goab009 |
work_keys_str_mv | AT goldowskyalexander isthereastandardizedpracticeforthedevelopmentofinternationalulcerativecolitisandcrohnsdiseasetreatmentguidelines AT senrohan isthereastandardizedpracticeforthedevelopmentofinternationalulcerativecolitisandcrohnsdiseasetreatmentguidelines AT hoffmangila isthereastandardizedpracticeforthedevelopmentofinternationalulcerativecolitisandcrohnsdiseasetreatmentguidelines AT feuersteinjosephd isthereastandardizedpracticeforthedevelopmentofinternationalulcerativecolitisandcrohnsdiseasetreatmentguidelines |